Crossmark

Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies

Crossref DOI link: https://doi.org/10.1007/s11095-021-03132-7

Published Online: 2021-12-13

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jindal, Akshita

Singh, Rishav

Tomar, Sakshi

Dureja, Janhvi

Karan, Maninder

Chadha, Renu
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-01
More Information

Article History

Received: 12 August 2021

Accepted: 22 October 2021

First Online: 13 December 2021

Declarations

:

: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Financial support was provided by Indian Council for Medical Research (ICMR), New Delhi, India.

Document is current

Any future updates will be listed below